Background:

SMAGP (small transmembrane and glycosylated protein) is a 97 amino acid single-pass type III membrane protein that localizes to the membrane of cytoplasmic vesicles. Existing as a murine-specific protein, SMAGP is thought to play a role in epithelial cell-cell contacts and, via its ability to control cell adhesion, may be involved in tumor formation, as well as overall tumor invasiveness and metastasis. SMAGP is subject to post-translational O-glycosylation which is thought to be modified with sialic acid residues. The gene encoding SMAGP maps to murine chromosome 15.

Applications:

ELISA, IHC

Name of antibody:

SMAGP

Immunogen:

Synthetic peptide of human SMAGP

Full name:

small cell adhesion glycoprotein

Synonyms：

hSMAGP

SwissProt:

Q0VAQ4

ELISA Recommended dilution:

1000-2000

IHC positive control:

Human breast cancer and Human brain

IHC Recommend dilution:

25-100